share_log

Benchmark Maintains Buy on Nutex Health, Lowers Price Target to $1.5

Benchmark Maintains Buy on Nutex Health, Lowers Price Target to $1.5

基准指数维持对Nutex Health的买入,将目标价下调至1.5美元
Benzinga ·  2023/11/14 09:16

Benchmark analyst Bill Sutherland maintains Nutex Health (NASDAQ:NUTX) with a Buy and lowers the price target from $2.5 to $1.5.

基准分析师比尔·萨瑟兰维持Nutex Health(纳斯达克股票代码:NUTX)的买入,并将目标股价从2.5美元下调至1.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发